Search research articles
Contact Us
Filters
Showing results (31-40 of 120) with videos related to
Page
of 12
Sort By:
Hepatology (Baltimore, Md.)
|
October 28, 2010
Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells
Miroslaw Kornek, Yury Popov, Towia A Libermann, et al.
The American Journal of Gastroenterology
|
March 16, 2016
The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease
Elliot B Tapper, Tracy Challies, Imad Nasser, et al.
Journal of Hepatology
|
October 12, 2007
The clinical significance of persistently normal ALT in chronic hepatitis B infection
Michelle Lai, Benjamin J Hyatt, Imad Nasser, et al.
Hepatology (Baltimore, Md.)
|
March 30, 2007
Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis
Zachary D Goodman, Robert L Becker, Paul J Pockros, et al.
Gastroenterology Clinics of North America
|
May 19, 2010
Lith genes and genetic analysis of cholesterol gallstone formation
Helen H Wang, Piero Portincasa, Nezam H Afdhal, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 13, 2004
Lack of the intestinal Muc1 mucin impairs cholesterol uptake and absorption but not fatty acid uptake in Muc1-/- mice
Helen H Wang, Nezam H Afdhal, Sandra J Gendler, et al.
Gastroenterology
|
July 13, 2006
Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice
Helen H Wang, Nezam H Afdhal, Sandra J Gendler, et al.
Journal of Lipid Research
|
January 3, 2004
Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation
Helen H Wang, Nezam H Afdhal, Sandra J Gendler, et al.
Biomacromolecules
|
May 10, 2005
Viscoelastic properties and dynamics of porcine gastric mucin
Jonathan Celli, Brian Gregor, Bradley Turner, et al.
Plos One
|
February 25, 2016
Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score
Elliot B Tapper, M G Myriam Hunink, Nezam H Afdhal, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 120) with videos related to
Sort By:
Page
of 12
Hepatology (Baltimore, Md.)
|
October 28, 2010
Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells
Miroslaw Kornek, Yury Popov, Towia A Libermann, et al.
The American Journal of Gastroenterology
|
March 16, 2016
The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease
Elliot B Tapper, Tracy Challies, Imad Nasser, et al.
Journal of Hepatology
|
October 12, 2007
The clinical significance of persistently normal ALT in chronic hepatitis B infection
Michelle Lai, Benjamin J Hyatt, Imad Nasser, et al.
Hepatology (Baltimore, Md.)
|
March 30, 2007
Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis
Zachary D Goodman, Robert L Becker, Paul J Pockros, et al.
Gastroenterology Clinics of North America
|
May 19, 2010
Lith genes and genetic analysis of cholesterol gallstone formation
Helen H Wang, Piero Portincasa, Nezam H Afdhal, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 13, 2004
Lack of the intestinal Muc1 mucin impairs cholesterol uptake and absorption but not fatty acid uptake in Muc1-/- mice
Helen H Wang, Nezam H Afdhal, Sandra J Gendler, et al.
Gastroenterology
|
July 13, 2006
Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice
Helen H Wang, Nezam H Afdhal, Sandra J Gendler, et al.
Journal of Lipid Research
|
January 3, 2004
Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation
Helen H Wang, Nezam H Afdhal, Sandra J Gendler, et al.
Biomacromolecules
|
May 10, 2005
Viscoelastic properties and dynamics of porcine gastric mucin
Jonathan Celli, Brian Gregor, Bradley Turner, et al.
Plos One
|
February 25, 2016
Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score
Elliot B Tapper, M G Myriam Hunink, Nezam H Afdhal, et al.
Page
of 12